Review:
Bethesda System For Reporting Thyroid Cytopathology
overall review score: 4.5
⭐⭐⭐⭐⭐
score is between 0 and 5
The Bethesda System for Reporting Thyroid Cytopathology (BSRTC) is a standardized framework used by cytopathologists to interpret and report thyroid fine-needle aspiration (FNA) biopsy results. Established to improve communication, ensure consistency, and guide clinical management, the system categorizes thyroid lesions into six defined diagnostic categories with associated risk stratifications and recommended management protocols.
Key Features
- Standardized diagnostic categories for thyroid FNA cytology
- Six main categories: non-diagnostic, benign, AUS/FLUS (Atypia of undetermined significance/Follicular lesion of undetermined significance), follicular neoplasm/suspicious for follicular neoplasm, suspicious for malignancy, malignant
- Provides implied risk of malignancy associated with each category
- Guides clinical management decisions based on cytology interpretation
- Widely adopted internationally for consistency in reporting
- Facilitates research and data comparison across institutions
Pros
- Enhances clarity and uniformity in thyroid cytology reports
- Aids clinicians in making informed treatment choices
- Reduces diagnostic ambiguity and inter-observer variability
- Supported by extensive research and clinical guidelines
- Improves patient care through standardized communication
Cons
- Some categories (e.g., AUS/FLUS) carry uncertain risk assessments, leading to management variability
- Requires specific training and familiarity for accurate application
- Potential for over-reliance on cytology alone without adjunct testing in certain cases
- May not fully account for all atypical presentations or rare lesions